3 results match your criteria: "International Institute of Behavioral Medicines[Affiliation]"
Minerva Pediatr (Torino)
October 2024
Department of Information Engineering, University of Brescia, Brescia, Italy.
Introduction: The overall contribution of physical exercise on the management of disabling consequences of leukemia and lymphoma in children is missing. The aim of this scoping review (ScoR) was to systematically collect, map and present the current research evidence concerning studies reporting data on physical exercise among children with leukemia and lymphoma.
Evidence Acquisition: This ScoR was performed by adopting recommendations of the 2020 version of the "Joanna Briggs Institute Methodological Guidance", along with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews.
Eur J Phys Rehabil Med
December 2024
Department of Clinical Psychology, International Institute of Behavioral Medicines, Sevilla, Spain.
Background: There is growing evidence on Commitment Therapy for people with low back pain (LBP). A self-reported questionnaire is lacking which evaluates commitment by relying on the most recommended actions, the most important core outcome domains, and the most evidenced treatment options.
Aim: To describe the development and psychometric validation of the Work In Progress (WIP) questionnaire.
Trials
November 2023
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Upper limb lymphedema (ULLy) is an external (and/or internal) manifestation of lymphatic system insufficiency and deranged lymph transport for more than 3 months and frequently affects people as a consequence of breast cancer (BC). ULLy is often underestimated despite diminished motor skills, mood, and cognitive-behavioral complaints negatively condition the health-related quality of life (HRQoL) of persons. BC can also metastasize to the jawbone, further impacting on the HRQoL.
View Article and Find Full Text PDF